U.S. Capital Wealth Advisors’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,118
Closed -$15K 747
2022
Q1
$15K Buy
+11,118
New +$23.8K ﹤0.01% 704

Other funds holding AFIB

U.S. Capital Wealth Advisors's AFIB Position: Q2 2022 in Review

U.S. Capital Wealth Advisors sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 11,118 shares — an estimated $15K sold.

U.S. Capital Wealth Advisors first reported a position in AFIB in Q1 2022 and held it in 1 quarter. The position peaked at $15K in Q1 2022. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • U.S. Capital Wealth Advisors reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 11,118 Acutus Medical Inc shares in Q2 2022, an estimated $15K.
  • U.S. Capital Wealth Advisors first reported a position in Acutus Medical Inc in Q1 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Acutus Medical Inc position peaked at $15K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on U.S. Capital Wealth Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.